Exploring Multi Marker Modelling to Inform Prediction Modelling for Optimizing Patient Selection
- Exploring multi-marker modeling and the potential of combining biomarkers to improve prognostication and patient selection for ILD clinical trials
- Assessing how biomarkers can be used to predict treatment response in ILD
- Evaluating multi-modal biomarker strategies that incorporate data from clinical, genomic, proteomic, and imaging domains to improve outcome discrimination in ILD